Grateful to be a part of this powerhouse team to develop a personalized ASO drug for these brave girls!
@HastingsLab @DrJWeimer @forebatten
Announcing Zebronkysen: Amelia & Makenzie receive personalized ASO drug. This milestone would not be possible without the incredible support of the ForeBatten community and the passionate development team.
More information on this exciting news is on forebatten.org/
Today is International Batten Disease Awareness Day. To learn more about CLN3 Batten disease and the research we are doing in the @HastingsLab, check out our latest publication. I’m honored to work with such an amazing team! @MattyStratty22 @DrJWeimer @forebatten
Protracted CLN3 Batten disease in mice that genetically model an exon skipping therapeutic approach #MTNA dlvr.it/Sq9fjM
Exciting work from the Hastings lab! Fantastic job! @HastingsLab @Wren_Wren @RFUniversity
Open reading frame correction using splice-switching antisense oligonucleotides for the treatment of cystic fibrosis pnas.org/content/119/3/e2114…
3
Just published our work in Nature Medicine! Thankful to be able to work with such a great group of researchers.
nature.com/articles/s41591-0…
@HastingsLab @DrJWeimer
Exciting data from the @HastingsLab! Awesome work @Wren_Wren!
#antisense #oligonucleotides
Antisense oligonucleotide-mediated correction of CFTR splicing improves chloride secretion in cystic fibrosis patient-derived bronchial epithelial cells academic.oup.com/nar/advance…
2
AMG Announces Appointment of Mr. Thomas Centa as President of AMG Vanadium globenewswire.com/news-relea…
1



